Mintr Compass
$67.81
BMY · Bristol Myers Squibb
95 Top-Tier · Mid Horizon
95Top-Tier
Price Action74
Business Quality65
Market Confidence57
AI READ as of 2026-08-20
Trading Firming
  • Recent news coverage is largely positive
  • Price movement shows signs of gathering upward momentum
  • Current price sits near a favorable level relative to recent history
Investing Top-Tier
  • The company maintains a solid overall quality profile
  • Shares are priced attractively compared to their underlying worth
  • The healthcare industry offers a stable foundation for long-term outlooks
Price & Momentum · Trading
Technical
43
Rel. Strength
80
Momentum
77
Proximity
95
Sentiment
96
Business & Value · Investing
Quality
78
Balance Sheet
57
Growth
54
Valuation
71
Analyst
18
Open BMY in Compass →
Ratings current as of 2026-08-19. Algorithmic percentile rankings from historical and delayed data — not investment advice or a recommendation to buy or sell any security. Markets involve risk including loss of principal. Methodology · Terms · Privacy